loading...

View Patent Images (PDF)
(Registered users only)

Abstract

Other References

• JE Ahlskog, et al., "Adjunctive Cabergoline Therapy of Parkinson's Disease: Comparison with Placebo and Assessment of Dose Response and Duration of Effect," Clin. Neuropharmacol, 1996; 19:202-212
• S Akpinar, "Restless Legs Syndrome Treatment with Dopaminergic Drugs," Clinical Neuropharmacology, 1987; 10:69-79
• RP Allen, et al., "Augmentation of the Restless Legs Syndrome with Carbidopa/Levodopa" Sleep, 1996; 19(3):205-13
• Anonymous Author, "My Doctor Prescribed Sinemet for my Restless Legs and it was a Catastrophe." Johns Hopkins Medical Letter, Health After 50, 1998; 10 (12) 8
• Anonymous Author, "Restless Legs Syndrome Often Not Recognized, May be Misdiagnosed," Geriatrics, 1998; 53(2): 101
• PM Becker, et al., "Dopaminergic Agents in Restless Legs Syndrome and Periodic Limb Movements of Sleep: Response and Complications of Extended Treatment in 49 Cases," 1993; Sleep, 16(8); pp. 713-716
• D Boghen, et. al., "The Treatment of Restless legs Syndrome with Clonazepam: A Prospective Controlled Study," Can J Neurol Sci, 1986; 13:245-247
• B Bornstein, "Restless Legs," Psychiat Neurol, 1961; 141:165-201.1
• C Brodeur, et. al., "Treatment of RLS and PMS with L-dopa: A Double-blind Controlled Study," Neurology, 1988, 35:1845-1848
• N Callaghan, "Restless Legs Syndrome in uremic Neuropathy," Neurology, 1966; 16:359-361
• RM Coleman, "Periodic Movements in Sleep (Nocturnal Myoclonus) and Restless Legs Syndrome." In: Guilleminault C, (ed) Sleeping and Walking Disorders: Indications and Techniques, 1982; Menlo Park: Addison Wesley; 265-295
• V Collado-Seidel, et al., "A Controlled Study of Additional sr-L-dopa in L-dopa-Responsive Restless Legs Syndrome with Late-Night Symptoms," Neurology, 1999; 52:285-290
• CJ Earley, et al., "Pergolide and Carbidopa/Levodopa Treatment of the Restless Legs Syndrome and Periodic Leg Movements in Sleep in a Consecutive Series of Patients," Sleep 1996; 19(10):801-10
• KA Ekbom, "Restless Legs," Acta Medica Scandinavica, 1945; suppl. 158:1-123
• KA Ekbom, "Restless Legs Syndrome," Neurology, 1960; 10:868-873
• RG Fariello, "Pharmacodynamic and Pharmacokinetic Features of Carbergoline," Drugs, 1997; 55:S2, 10-16
• A Feigen, "Restless Legs Syndrome," JAMA, 1995; 274 (15) 1191-2
• B Frankel, "Restless Legs Syndrome," JAMA, 1974; 230:1302-1303
• LI Golbe, "Pregnancy and Movement Disorders," Neurologic Clinics, 1994; 12/3 (497-508)
• C Gorman, et al., "Symptoms of Restless Legs," Arch Intern Med, 1965; 115:155-60
• C Guilleminault, et al., "Dopaminergic Treatment of Restless Legs and Rebound Phenomenon," Neurology, 1993; 43(2):445
• D Harriman, et al., "Ekbom's Syndrome and Burning Paraesthesiae," Brain, 1970; 93:393-406
• EM Heiman, et al., "Lithium-aggravated Nocturnal Myoclonus and Restless Legs Syndrome [letter]," American Journal of Psychiatry, 1986; 143:1191-1192
• F Heinze, et al., "Restless Legs and Orthostatic Hypotension in Primary Amyloidosis," Arch Neurol, 1967; 16:497-500
• W Hening, et al., "The Cortical Premovement Potentials in RLS Jerks," Sleep Res, 1991; 20:255
• WA Hening, et. al., "Dyskinesias while awake and periodic movements in Sleep in Restless Legs Syndrome: Treatment with Opioids," Neurology; 1986; 36:1363-1366
• S Iannaccone, et al., "Evidence of Peripheral Axonal Neuropathy in Primary Restless Legs Syndrome," Movement Disorders, 1995; 10:2-9
• S Jorgensen, et al., "Restless Legs Syndrome,"--Abstract, Ugeskrift for Laeger, 1989; 151 (11) 670-1
• PW Kaplan, et al., "A Double-Blind, Placebo-Controlled Study of the Treatment of Periodic Limb Movements in Sleep using Carbidopal/Levodopa and Propoxyphene," Sleep, 1993; 16 (8) 717-23
• S Kotagal, et al., "Nocturnal Myoclonus--A Sleep Disturbance in Children with Leukemia," Annals of Neurology, 1984; 16:392
• E Lugaresi, et al., "Nocturnal Myoclonus and Restless Legs Syndrome," In: S Fahn et al. (eds), Advances in Neurology, 1986; vol. 43: Myoclonus, New York: Raven Press; 295-307
• MW Mahowald, et al., "Parasomnias Including in the Restless Legs Syndrome," Clinics in Chest Medicine, 1998; 19/1 (183-202)
• P Martinelli, et al., "Nocturnal Myoclonus, Restless Legs Syndrome, and Abnormal Electrophysiological Findings," Ann Neurol, 1987; 21:515
• WB Matthews, "Iron Deficiency and Restless Legs," Br Med J, 1976; 1-898
• M Miyagi, et al., "Dopamine Receptor Affinities in vitro and Steriotypic Activities in vivo of Cabergoline in Rats," Biol. Pharm. Bull., 1996; 19L 1210-1213
• H Moldofsky, et al., "Sleep-related Myoclonus in Rheumatic Pain Modulation Disorder (Fibrositis Syndrome) and in Excessive Daytime Somnolence," Psychosomatic Medicine, 1984; 46:145-151
• J Montplaisir, et al., "Familial Restless Legs with Periodic Movements in Sleep:Electrophysiological, Biochemical, and Pharmacological Study," Neurology, 1985; 35:130-134
• J Montplaisir, et. al., "Restless Legs Syndrome and Periodic Movements in Sleep: Physiopathology and Treatment with L-dopa," Clinical Neuropharmacology, 1986; 9:456-463
• J Montplaisir, et al., "The Effect of Pramipexole, A D3 Preferring Agonist, on the Restless Legs Syndrome (RLS)," Neurology, 1999; vol. 52; p. 938
• J Montplaisir, et al., "The Effect of Pramipexole on Sensory and Motor Manifestations of the Restless Leg Syndrome," American Academy of Neurology, Minneapolis Convention in Minnesota, Apr. 29, 1998
• J. Montplasir, et al., "The Treatment of the Restless Leg Syndrome With or Without Periodic Leg Movements in Sleep," Sleep, 1992; 15(5): 391-395
• SS Mosko, et al., "Somatosensory and Brainstem Auditory Evoked Responses in Sleep-related Periodic Leg Movements," Sleep, 1986; 9:399-404
• S Noel, et al., "Low Dosage of Pergolide in the Treatment of Restless Legs Syndrome," Acta Neurologica Belgica, 1998; 98 (1) 52-3
• M Oechsner, "[Idiopathic Restless Legs Syndrome: Combination Therapy with Levodopa and *** Ropinirole***]," Aktuelle Neurologie, 1998; 25/5 (190-192)
• Ondo, W, "Ropinirole for Restless Legs Syndrome," Mov Disord., 1999; 1, pp. 138-140
• G Reynolds, et al., "Restless Leg Syndrome and Rheumatoid Arthritis," British medical Journal, 1986; 292:659-660
• E Ruiz-Primo, Is Nocturnal Myoclonus a Common Sleep Disturbance in Children with Leukaemia, Dev Med Child Neurol, 1987; 29:833
• F Salvi, et al., "Restless Legs Syndrome and Nocturnal Myclonus: Initial Clinical Manifestation of Familial Amyloid Polyneuropathy," J Neurol Neurosurg Psychiatry, 1990; 53:522-525
• R Sandyk, et al., "L-Dopa in Uremic Patients with the Restless Legs Syndrome," Int J Neurosci, 1987; 35:233-235
• MH Silber, et al., "Pergolide in the Management of Restless Legs Syndrome: An Extended Study," Sleep 1997; 20(10):878-82
• MH Silber, et al., "Restless Legs Syndrome," Mayo Clinic Proceedings, 1997; 72/3 (261-264)
• JS Simpson, "Familial Akathisia and Depression Treated with Mefazodone [letter]," Canadian Journal of Psychiatry, Revue Canadienne De Psychiatre, 1996; 41 (8) 539-40
• JD Spillane, "Restless Legs Syndrome in Chronic Pulmonary Diseases," Br Med J, 1970; 4:796-798
• J Staedt, et al., "Nightly Myoclonus Syndrome (NMS) and Restless Legs Syndrome (RLS)--Review and Case Report," Fortschr. Neurol. Psychiat. 62, 1994; pp. 88-93
• J Staedt, et al, "Pergolide: Treatment of Choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Long Term Follow up on Pergolide. Short Communication," Journal of Neural Transmission, 1998; 105 (2-3) 265-8
• J Staedt, et al., "Pergolide: Treatment of Choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). A Double-Blind Randomized Crossover Trial of Pergolide versus L-Dopa," Journal of Neural Transmission, 1997; 104 (4-5) 461-8
• K Stiasny, et al., "Cabergoline in RLS," ENS, Nice Abstract, 1998
• MJ Thorpy, Chairman, Diagnostic Classification Steering Committee in International Classification of Sleep Disorders: Diagnostic and Coding Manual--Table of Contents, 1990; American Sleep Disorders Association
• C Trenkwalder, et al., "L-Dopa in Uremic and Idiopathic Restless Legs Syndrome: a double-blind, crossover trial," Sleep, 1995; 18:681-688
• C Trenkwalder, et al., "Therapy of Idiopathic and Uremic Restless legs Syndrome Therapie des idiopathischen und uramischen Restless-Legs-Syndroms," Nervenarzt, 1996; 67 (4) 265-76, Ref: 79
• PT Trzepacz, et. al., "Response to Opioids in Three Patients with Restless Legs Syndrome," Ann J Psychiatry, 1984; 141:993-995
• C Von Scheele, "Levodopa in Restless Legs," Lancet, 1986; 2:426-427
• C Von Scheele, "Long-term Effect of Dopaminergic Drugs in Restless Legs. A 2-year Follow-up," Archives of Neurology, 1990; 47 (11) 1223-4
• AS Walters, et al., "A Double-blind Randomized Crossover Trial of Bromocriptine and Placebo in Restless Leg Syndrome," Ann Neurol, 1988; 24:455-458
• AS Walters, "Towards a Better Definition of the Restless Legs Syndrome," The International Study Group, Mov Disord, 1995; 10(5):634-42
• JC Ware, et al., "Nocturnal Myoclonus and Tricyclic Antidepressants," Sleep Research, 1984; 13:72
• S Watanabe, et al., "Periodic Leg Movements During Either Epidural or Spinal Anesthesia in an Elderly Man without Sleep-related (Nocturnal) Myoclonus," Sleep, 1990; 13:262-266
• LR Wechsler, et al., "Periodic Leg Movements of Sleep (Nocturnal Myoclonus): An Electrophysiological Study," Annals of Neurology, 1986; 19:168-173
• TC Wetter, et al., "A Polysomnographic, Controlled Study of Pergolide in the Treatment of Restless Legs Syndrome," Neurology, 1998; 50(4):A69
• J Winkelman, et al., "Treatment of Restless Leg Syndrome with Pergolide--An Open Clinical Trial," Mov Disord, 1998; 13(3):566-